{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:32:42Z","timestamp":1781195562466,"version":"3.54.1"},"reference-count":26,"publisher":"Korean College of Neuropsychopharmacology","issue":"1","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2018,2,28]]},"DOI":"10.9758\/cpn.2018.16.1.57","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T19:48:42Z","timestamp":1517773722000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting"],"prefix":"10.9758","volume":"16","author":[{"given":"Ulku Akyol","family":"Ardic","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Denizli State Hospital, Denizli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"K\u00fc\u00e7\u00fckk\u00f6se","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Aydin State Hospital, Aydin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim Berrin","family":"Inci","sequence":"additional","affiliation":[{"name":"nstitute on Drug Abuse, Toxicology and Pharmaceutical Science, Ege University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ey\u00fcp Sabri","family":"Ercan","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Ege University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4713","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1037\/0012-1649.26.5.745"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8624.2006.00912.x"},{"key":"ref3","unstructured":"Tremblay, RE, Nagin, DS, S\u00e9guin, JR, Zoccolillo, M, Zelazo, PD, and Boivin, M (2005). Physical aggression during early childhood: trajectories and predictors. Can Child Adolesc Psychiatr Rev. 14, 3-9."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015754122318"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Publishing","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12081129"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10802-013-9778-0"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1037\/0012-1649.35.2.335"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10802-012-9673-0"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1037\/0012-1649.39.6.1020"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1330.023"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-013-0498-3"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-5-10"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.6.1125"},{"key":"ref15","unstructured":"Guy, W (1976). ECDEU assessment manual for psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration; National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.02.013"},{"key":"ref17","unstructured":"Tutkunkarda\u015f, MD, and Abali, O (2011). Long acting risperidone in an adolescent with conduct disorder: A case report. Psychopharmacol Bull. 44, 69-72."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2012-0999"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(03)00006-7"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-171"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/15622970701530917"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00761.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.015"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Boarati, MA, Wang, YP, Ferreira-Maia, AP, Cavalcanti, AR, and Fu-I, L (2013). Six-month open-label follow-up of risperidone long-acting injection use in pediatric bipolar disorder. Prim Care Companion CNS Disord. 15.","DOI":"10.4088\/PCC.12m01368"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1227"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2018\/016\/cpn016-01-07.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2018\/016\/cpn016-01-07.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:52:08Z","timestamp":1570679528000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2018.16.1.57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2,28]]}},"alternative-id":["10.9758\/cpn.2018.16.1.57"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2018.16.1.57","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"value":"1738-1088","type":"print"},{"value":"2093-4327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2018.16.1.57","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2018.16.1.57","name":"the_journal","label":"Clin Psychopharmacol Neurosci","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2016-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2018 The Korean College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}